These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8257463)

  • 41. Screening for cystic fibrosis. Should begin with cascade screening.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Oct; 309(6958):877-8. PubMed ID: 7950637
    [No Abstract]   [Full Text] [Related]  

  • 42. Screening for carriers of cystic fibrosis among partners of people heterozygous for the disease.
    Sennhauser FH; Liechti-Gallati S; Moser H
    BMJ; 1990 Nov; 301(6760):1081. PubMed ID: 2103736
    [No Abstract]   [Full Text] [Related]  

  • 43. Principles and practicalities of carrier screening: attitudes of recent parents.
    Green JM
    J Med Genet; 1992 May; 29(5):313-9. PubMed ID: 1583658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
    Bekker H; Modell M; Denniss G; Silver A; Mathew C; Bobrow M; Marteau T
    BMJ; 1993 Jun; 306(6892):1584-6. PubMed ID: 8329922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing for cystic fibrosis using allelic association.
    Ivinson AJ; Read AP; Harris R; Super M; Schwarz M; Clayton Smith J; Elles R
    J Med Genet; 1989 Jul; 26(7):426-30. PubMed ID: 2746614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clarification needed to cystic fibrosis model.
    Gettig B; Venne V
    Am J Obstet Gynecol; 1993 Nov; 169(5):1358-9. PubMed ID: 8238207
    [No Abstract]   [Full Text] [Related]  

  • 47. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 48. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 50. Carrier screening for cystic fibrosis.
    Beaudet AL
    Am J Hum Genet; 1990 Oct; 47(4):603-5. PubMed ID: 2220802
    [No Abstract]   [Full Text] [Related]  

  • 51. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 52. Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view.
    Di Pietro ML; Teleman AA; Gonzalez-Melado FJ; Zace D; Di Raimo FR; Lucidi V; Refolo P
    Clin Ter; 2018; 169(2):e71-e76. PubMed ID: 29595869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs, effects, and savings of screening for cystic fibrosis gene carriers.
    Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD
    J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simple method for cystic fibrosis carrier screening.
    Molina Cabañero JC; Perez Jurado LA; Raskin S; Vicario JL; Balas Perez A; Garcia Novo MD
    Lancet; 1992 Oct; 340(8825):983-4. PubMed ID: 1357395
    [No Abstract]   [Full Text] [Related]  

  • 56. The ethics of cystic fibrosis carrier screening: where do we stand?
    De Braekeleer M; Mélançon MJ
    Am J Hum Genet; 1990 Sep; 47(3):580-1. PubMed ID: 2393029
    [No Abstract]   [Full Text] [Related]  

  • 57. Sodium transport in cystic fibrosis fibroblasts.
    N Engl J Med; 1981 Apr; 304(16):974-6. PubMed ID: 7207549
    [No Abstract]   [Full Text] [Related]  

  • 58. Screening for cystic fibrosis.
    Dodge JA; Ryley HC
    Arch Dis Child; 1982 Oct; 57(10):774-80. PubMed ID: 7138066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for cystic fibrosis carriers.
    Schulman JD; Maddalena A; Black SH; Bick DP
    Am J Hum Genet; 1990 Oct; 47(4):740. PubMed ID: 2220812
    [No Abstract]   [Full Text] [Related]  

  • 60. Statement of the American Society of Human Genetics on cystic fibrosis carrier screening.
    Am J Hum Genet; 1992 Dec; 51(6):1443-4. PubMed ID: 1463021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.